Redwoods Merger Partner ANEW Medical Announced A Patent In China For The Use Of ANEW's Klotho Protein And Klotho Gene Delivery And Expression Systems In The Treatment Of Cognition, Memory And Neurodegenerative Diseases
Redwoods Merger Partner ANEW Medical Announced A Patent In China For The Use Of ANEW's Klotho Protein And Klotho Gene Delivery And Expression Systems In The Treatment Of Cognition, Memory And Neurodegenerative Diseases
ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. In May 2023, ANEW announced its proposed merger with a special purpose acquisition company ("SPAC") called Redwoods (NASDAQ:RWOD).
ANEW MEDICAL, INC.（“ANEW” 或 “公司”）（OTCPK：LEAS）是一家总部位于美国的生物技术公司（“ANEW”），专注于开发影响衰老和年龄相关疾病的细胞和基因疗法，宣布已在中国获得批准并颁发了一项专利，编号为CN 117126829 A，用于使用ANEW的Klotho蛋白和Klotho基因传递和表达系统来治疗认知、记忆和神经退行性疾病。2023年5月，ANEW宣布了与一家名为Redwoods（纳斯达克股票代码：RWOD）的特殊目的收购公司（“SPAC”）的拟议合并。
译文内容由第三方软件翻译。